期刊
PLOS ONE
卷 16, 期 2, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0241281
关键词
-
资金
- National Natural Science Foundation of China [81470765, 81271182]
FGF9 plays a crucial role in early chondrogenesis, partly through the AKT/GSK-3 β pathway, regulating cartilage matrix formation and gene expression. Inhibition of FGF9 suppresses AKT and GSK-3 β phosphorylation, leading to inhibited chondrocyte differentiation, which can be compensated by the activation of AKT.
Fibroblast growth factor signaling is essential for mammalian bone morphogenesis and growth, involving membranous ossification and endochondral ossification. FGF9 has been shown to be an important regulator of endochondral ossification; however, its role in the early differentiation of chondrocytes remains unknown. Therefore, in this study, we aimed to determine the role of FGF9 in the early differentiation of chondrogenesis. We found an increase in FGF9 expression during proliferating chondrocyte hypertrophy in the mouse growth plate. Silencing of FGF9 promotes the growth of ATDC5 cells and promotes insulin-induced differentiation of ATDC5 chondrocytes, which is due to increased cartilage matrix formation and type II collagen (col2a1) and X (col10a1), Acan, Ihh, Mmp13 gene expression. Then, we evaluated the effects of AKT, GSK-3 beta, and mTOR. Inhibition of FGF9 significantly inhibits phosphorylation of AKT and GSK-3 beta, but does not affected the activation of mTOR. Furthermore, phosphorylation of inhibited AKT and GSK-3 beta was compensated using the AKT activator SC79, and differentiation of ATDC5 cells was inhibited. In conclusion, our results indicate that FGF9 acts as an important regulator of early chondrogenesis partly through the AKT/GSK-3 beta pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据